ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.941,27
-0,17%
Brent Oil
84,165
0,26%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Innovation Pharmaceuticals Inc (CE) (IPIX)

  7. Innovation Pharmaceuticals Inc (CE) (IPIX) Notícias

IPIX

Innovation Pharmaceuticals (CE) (IPIX)

Innovation Pharmaceuticals Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:IPIX
DataHoraFonteTítuloCódigoCompanhia
01/02/202410:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/11/202318:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/11/202310:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202310:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/05/202309:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/02/202309:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
04/01/202318:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202217:01Edgar (US Regulatory)Annual Report (10-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202213:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/07/202217:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/11/202111:20InvestorsHub NewsWireIQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should CloseUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/10/202108:00InvestorsHub NewsWireCEO Presenting on the Emerging Growth Conference on October 13 Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
29/09/202109:00InvestorsHub NewsWireCEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202108:24InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% GrowthUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
21/07/202107:47InvestorsHub NewsWireNightfood, Inc. (OTCQB: NGTF) Significant Retail ExpansionUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/06/202108:00InvestorsHub NewsWireThe Emerging Growth Conference is Today.  Register Now.USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/03/202108:37InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company HistoryUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/02/202118:47Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/02/202108:48InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating TargetUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/02/202108:52InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New ProductsUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
22/12/202010:05InvestorsHub NewsWireBiotech Companies; Recent Milestones and Potential UpsideUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/12/202008:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/11/202008:48InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance FeaturesUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/07/202007:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/07/202018:09Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
16/04/202009:00InvestorsHub NewsWireCannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here!USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
26/12/201919:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
17/10/201918:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
13/08/201917:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/08/201917:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:IPIX

Seu Histórico Recente

BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
CMIN3
CSN Mineracao S.A ON
BOV
COGN3
COGNA ON
BOV
LUPA3
LUPATECH ON
BOV
PDTC3
Padtec ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
CASH3
Meliuz S.A ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados